Search
for
Sort by
Research 271–300 of 1000+
- Multiple minute digitate hyperkeratosis
- Telogen Effluvium Associated with Albendazole Therapy
- SUSPECTED CUTANEOUS DRUG TOXICITY IN RHEUMATOID ARTHRITIS—AN EVALUATION
- Skin eruptions specific to pregnancy: an overview
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Diseases of the Hair and Nails
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- A Case Report of Male Systemic Lupus Erythematous with Antinuclear Antibodies-Negative: A Challenging Diagnosis
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
- Cutaneous Reactions to Drugs
- Cytokines
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Dermatologic Adverse Events from Cancer Treatments
- Management of Toxicities of Targeted Therapies
- Current and future pharmacotherapy for alopecia areata
- Inherited Disorders of the Hair
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- New therapies for alopecia areata
- Alopecia Areata
- Current systemic treatment strategies for hidradenitis suppurativa
- British Hair and Nail Society
- Antihelminthic Drugs
- Cutaneous drug reactions
- Docetaxel-induced Psoriasis
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications